Beta (β) in Pharmaceuticals & Healthcare
How to interpret and apply beta (β) specifically when analyzing pharmaceuticals & healthcare stocks in India.
Quick Recap: What is Beta (β)?
Beta measures how much a stock's price moves relative to the overall market — a stock with beta > 1 is more volatile than the market, below 1 is less volatile.
Beta = Covariance(Stock, Market) ÷ Variance(Market)
How Beta (β) Works Differently in Pharmaceuticals & Healthcare
R&D intensive, regulatory risk (USFDA), patent cliffs, mix of domestic and export revenue.
Typical Ranges for Pharmaceuticals & Healthcare
Typical P/E (risk context)20-40x
General benchmark: Defensive stocks: 0.5-0.8, Market average: 1.0, Growth/Tech: 1.2-1.8
Example Pharmaceuticals & Healthcare Companies to Analyze
Use the Equiscale Screener → to filter pharmaceuticals & healthcare stocks by beta and other metrics.
Key Takeaways
- Beta (β) in pharmaceuticals & healthcare should be compared against sector peers, not the market average.
- Sector characteristics: R&D intensive, regulatory risk (USFDA), patent cliffs, mix of domestic and export revenue.
- Always cross-check with other metrics. No single ratio tells the full story.